Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection M. Croze, O. Dauwalder, O. Dumitrescu,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

O. Dauwalder, L. Landrieve, F. Laurent, M. de Montclos, F

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.

Gram-positive infections: lessons learnt and novel solutions

Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects D. Johnsson, P. Mölling,

The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300 E.L. Brown, O. Dumitrescu,

New epidemiology of Staphylococcus aureus infection in Asia

Comparative genomics and DNA array-based genotyping of pandemic Staphylococcus aureus strains encoding Panton-Valentine leukocidin S. Monecke, B. Berger-Bächi,

Gut bacterial microbiota and obesity

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Herpes zoster in non-hospitalized children

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects D. Johnsson, P. Mölling,

E. Lindberg, I. Adlerberth, A.E. Wold

N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair

Epidemiological data of staphylococcal scalded skin syndrome in France from 1997 to 2007 and microbiological characteristics of Staphylococcus aureus.

E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic A.S.

Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain A. Manzur, A.M. Dominguez, M. Pujol, M.P.M. González,

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Allelic variation in genes encoding Panton–Valentine leukocidin from community- associated Staphylococcus aureus D.J. Wolter, F.C. Tenover, R.V. Goering

Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

Sofie Arens, Jan Verhaegen, Ludo Verbist

Emergence and control of an outbreak of infections due to Panton-Valentine leukocidin positive, ST22 methicillin-resistant Staphylococcus aureus in a.

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia A. Budimir, R.H. Deurenberg, Z. Bošnjak,

Bacterial resistance—the clinical challenge

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria Inga Odenholt, Elisabeth Löwdin,

Strategies for managing today's infections

Panton–Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain

Comparative genomics and DNA array-based genotyping of pandemic Staphylococcus aureus strains encoding Panton-Valentine leukocidin S. Monecke, B. Berger-Bächi,

Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Spread of Staphylococcus aureus clinical isolates carrying Panton–Valentine leukocidin genes during a 3-year period in Greece V. Chini, E. Petinaki,

Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 T. Benfield, F. Espersen,

Antibacterial drug discovery in the 21st century

Typing of Panton-Valentine leukocidin-encoding phages carried by methicillin- susceptible and methicillin-resistant Staphylococcus aureus from Italy A.

P.M. Hawkey Clinical Microbiology and Infection

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Effect of antibiotics, alone and in combination, on Panton–Valentine leukocidin production by a Staphylococcus aureus reference strain O. Dumitrescu,

Statin use and clinical outcomes among pneumonia patients

P. Kaltsas, S. Want, J. Cohen Clinical Microbiology and Infection

Clinical Microbiology and Infection

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

C.P. Kelly Clinical Microbiology and Infection

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

O. Dauwalder, L. Landrieve, F. Laurent, M. de Montclos, F

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Serum ferritin levels in West Nile encephalitis

A. Manzur, F. Gudiol Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Microarray-based characterisation of a Panton–Valentine leukocidin-positive community- acquired strain of methicillin-resistant Staphylococcus aureus

Impact of antibiotic restrictions: the patient's perspective

The future of diagnostic bacteriology

Presentation transcript:

Serum antibodies against Panton–Valentine leukocidin in a normal population and during Staphylococcus aureus infection M. Croze, O. Dauwalder, O. Dumitrescu, C. Badiou, Y. Gillet, A.-L. Genestier, F. Vandenesch, J. Etienne, G. Lina Clinical Microbiology and Infection Volume 15, Issue 2, Pages 144-148 (February 2009) DOI: 10.1111/j.1469-0691.2008.02650.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Distribution of anti-Panton-Valentine leukocidin (PVL) antibody levels in patients with no evidence of Staphylococcus aureus infection. Clinical Microbiology and Infection 2009 15, 144-148DOI: (10.1111/j.1469-0691.2008.02650.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Distribution of anti-Panton-Valentine leukocidin (PVL) antibody levels in the different age groups of patients with no evidence of Staphylococcus aureus infection. Bars show median values. Clinical Microbiology and Infection 2009 15, 144-148DOI: (10.1111/j.1469-0691.2008.02650.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Distribution of anti-Panton-Valentine leukocidin (PVL) antibody levels in the three populations studied: 142 sera from patients with no evidence of Staphylococcus aureus infection (S0); 71 sera from patients with PVL-negative S. aureus infection, comprising 63 first sera (S1) and 8 second sera (S2); and 43 sera from patients with PVL-positive S. aureus infection, comprising 31 first sera (S1) and 12 second sera (S2). Bars show median values. Clinical Microbiology and Infection 2009 15, 144-148DOI: (10.1111/j.1469-0691.2008.02650.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions